In addition to differences in distribution, CTE p-tau lesions are unique in their molecular structure from tau aggregates in other neurodegenerative diseases, such as Alzheimer’s disease (AD) or aging-related tau astrogliopathy (ARTAG) [7–10]. This evidence concerns the gene MAPT and neurodegenerative disease.